Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 33

1.

Highlights of the Third Expert Forum of Asia-Pacific Laparoscopic Hepatectomy; Endoscopic and Laparoscopic Surgeons of Asia (ELSA) Visionary Summit 2017.

Park JI, Kim KH, Kim HJ, Cherqui D, Soubrane O, Kooby D, Palanivelu C, Chan A, You YK, Wu YM, Chen KH, Honda G, Chen XP, Tang CN, Kim JH, Koh YS, Yoon YI, Cheng KC, Duy Long TC, Choi GH, Otsuka Y, Cheung TT, Hibi T, Kim DS, Wang HJ, Kaneko H, Yoon DS, Hatano E, Choi IS, Choi DW, Huang MT, Kim SG, Lee SG.

Ann Hepatobiliary Pancreat Surg. 2018 Feb;22(1):1-10. doi: 10.14701/ahbps.2018.22.1.1. Epub 2018 Feb 26.

2.

Chemotherapy with or Without Definitive Radiation Therapy in Inoperable Pancreatic Cancer.

Zhong J, Switchenko J, Behera M, Kooby D, Maithel SK, McDonald MW, Lin JY, Cassidy RJ, El-Rayes B, Landry J, Patel PR.

Ann Surg Oncol. 2018 Apr;25(4):1026-1033. doi: 10.1245/s10434-017-6322-4. Epub 2018 Jan 11.

3.

Paraduodenal Pancreatitis: Imaging and Pathologic Correlation of 47 Cases Elucidates Distinct Subtypes and the Factors Involved in its Etiopathogenesis.

Muraki T, Kim GE, Reid MD, Mittal P, Bedolla G, Memis B, Pehlivanoglu B, Freedman A, Erbarut Seven I, Choi H, Kooby D, Maithel SK, Sarmiento JM, Krasinskas A, Adsay V.

Am J Surg Pathol. 2017 Oct;41(10):1347-1363. doi: 10.1097/PAS.0000000000000919.

PMID:
28795998
4.

Outcomes for patients with locally advanced pancreatic adenocarcinoma treated with stereotactic body radiation therapy versus conventionally fractionated radiation.

Zhong J, Patel K, Switchenko J, Cassidy RJ, Hall WA, Gillespie T, Patel PR, Kooby D, Landry J.

Cancer. 2017 Sep 15;123(18):3486-3493. doi: 10.1002/cncr.30706. Epub 2017 May 10.

5.

Research considerations in the evaluation of minimally invasive pancreatic resection (MIPR).

Barkun J, Fisher W, Davidson G, Wakabayashi G, Besselink M, Pitt H, Holt J, Strasberg S, Vollmer C, Kooby D; Minimally Invasive Pancreatic Resection Organizing Committee.

HPB (Oxford). 2017 Mar;19(3):246-253. doi: 10.1016/j.hpb.2017.01.005. Epub 2017 Mar 6. Review.

6.

Minimally invasive pancreatic resections: cost and value perspectives.

Conlon KC, de Rooij T, van Hilst J, Abu Hidal M, Fleshman J, Talamonti M, Vanounou T, Garfinkle R, Velanovich V, Kooby D, Vollmer CM; Minimally Invasive Pancreatic Resection Organizing Committee.

HPB (Oxford). 2017 Mar;19(3):225-233. doi: 10.1016/j.hpb.2017.01.019. Epub 2017 Mar 6.

7.

Current status of biomarker and targeted nanoparticle development: The precision oncology approach for pancreatic cancer therapy.

Zhu L, Staley C, Kooby D, El-Rays B, Mao H, Yang L.

Cancer Lett. 2017 Mar 1;388:139-148. doi: 10.1016/j.canlet.2016.11.030. Epub 2016 Dec 1.

8.

Non-ampullary-duodenal carcinomas: clinicopathologic analysis of 47 cases and comparison with ampullary and pancreatic adenocarcinomas.

Xue Y, Vanoli A, Balci S, Reid MM, Saka B, Bagci P, Memis B, Choi H, Ohike N, Tajiri T, Muraki T, Quigley B, El-Rayes BF, Shaib W, Kooby D, Sarmiento J, Maithel SK, Knight JH, Goodman M, Krasinskas AM, Adsay V.

Mod Pathol. 2017 Feb;30(2):255-266. doi: 10.1038/modpathol.2016.174. Epub 2016 Oct 14.

9.

A Phase 1 Study of Stereotactic Body Radiation Therapy Dose Escalation for Borderline Resectable Pancreatic Cancer After Modified FOLFIRINOX (NCT01446458).

Shaib WL, Hawk N, Cassidy RJ, Chen Z, Zhang C, Brutcher E, Kooby D, Maithel SK, Sarmiento JM, Landry J, El-Rayes BF.

Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2):296-303. doi: 10.1016/j.ijrobp.2016.05.010. Epub 2016 May 24.

PMID:
27475674
10.

Contemporary Management of Borderline Resectable and Locally Advanced Unresectable Pancreatic Cancer.

Shaib WL, Ip A, Cardona K, Alese OB, Maithel SK, Kooby D, Landry J, El-Rayes BF.

Oncologist. 2016 Feb;21(2):178-87. doi: 10.1634/theoncologist.2015-0316. Epub 2016 Feb 1. Review.

11.

Pancreatic Ductal Adenocarcinoma is Spread to the Peripancreatic Soft Tissue in the Majority of Resected Cases, Rendering the AJCC T-Stage Protocol (7th Edition) Inapplicable and Insignificant: A Size-Based Staging System (pT1: ≤2, pT2: >2-≤4, pT3: >4 cm) is More Valid and Clinically Relevant.

Saka B, Balci S, Basturk O, Bagci P, Postlewait LM, Maithel S, Knight J, El-Rayes B, Kooby D, Sarmiento J, Muraki T, Oliva I, Bandyopadhyay S, Akkas G, Goodman M, Reid MD, Krasinskas A, Everett R, Adsay V.

Ann Surg Oncol. 2016 Jun;23(6):2010-8. doi: 10.1245/s10434-016-5093-7. Epub 2016 Jan 29.

12.

Substaging of Lymph Node Status in Resected Pancreatic Ductal Adenocarcinoma Has Strong Prognostic Correlations: Proposal for a Revised N Classification for TNM Staging.

Basturk O, Saka B, Balci S, Postlewait LM, Knight J, Goodman M, Kooby D, Sarmiento JM, El-Rayes B, Choi H, Bagci P, Krasinskas A, Quigley B, Reid MD, Akkas G, Maithel SK, Adsay V.

Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1187-95. doi: 10.1245/s10434-015-4861-0. Epub 2015 Sep 11.

PMID:
26362048
13.

IGF1 Receptor Targeted Theranostic Nanoparticles for Targeted and Image-Guided Therapy of Pancreatic Cancer.

Zhou H, Qian W, Uckun FM, Wang L, Wang YA, Chen H, Kooby D, Yu Q, Lipowska M, Staley CA, Mao H, Yang L.

ACS Nano. 2015 Aug 25;9(8):7976-91. doi: 10.1021/acsnano.5b01288. Epub 2015 Aug 10.

14.

Laparoscopic versus open hepatic resection for hepatocellular carcinoma: improvement in outcomes and similar cost.

Martin RC 2nd, Mbah NA, St Hill R, Kooby D, Weber S, Scoggins CR, Maithel SK.

World J Surg. 2015 Jun;39(6):1519-26. doi: 10.1007/s00268-015-2974-z.

PMID:
25665672
15.

A nomogram to predict overall survival and disease-free survival after curative resection of gastric adenocarcinoma.

Kim Y, Spolverato G, Ejaz A, Squires MH, Poultsides G, Fields RC, Bloomston M, Weber SM, Votanopoulos K, Acher AW, Jin LX, Hawkins WG, Schmidt C, Kooby D, Worhunsky D, Saunders N, Levine EA, Cho CS, Maithel SK, Pawlik TM.

Ann Surg Oncol. 2015;22(6):1828-35. doi: 10.1245/s10434-014-4230-4. Epub 2014 Nov 12.

PMID:
25388061
16.

Conditional survival after surgical resection of gastric cancer: a multi-institutional analysis of the us gastric cancer collaborative.

Kim Y, Ejaz A, Spolverato G, Squires MH, Poultsides G, Fields RC, Bloomston M, Weber SM, Votanopoulos K, Acher AW, Jin LX, Hawkins WG, Schmidt C, Kooby D, Worhunsky D, Saunders N, Cho CS, Levine EA, Maithel SK, Pawlik TM.

Ann Surg Oncol. 2015 Feb;22(2):557-64. doi: 10.1245/s10434-014-4116-5. Epub 2014 Oct 7.

PMID:
25287440
17.

Management of biliary cystic tumors: a multi-institutional analysis of a rare liver tumor.

Arnaoutakis DJ, Kim Y, Pulitano C, Zaydfudim V, Squires MH, Kooby D, Groeschl R, Alexandrescu S, Bauer TW, Bloomston M, Soares K, Marques H, Gamblin TC, Popescu I, Adams R, Nagorney D, Barroso E, Maithel SK, Crawford M, Sandroussi C, Marsh W, Pawlik TM.

Ann Surg. 2015 Feb;261(2):361-7. doi: 10.1097/SLA.0000000000000543.

18.

Vein involvement during pancreaticoduodenectomy: is there a need for redefinition of "borderline resectable disease"?

Kelly KJ, Winslow E, Kooby D, Lad NL, Parikh AA, Scoggins CR, Ahmad S, Martin RC, Maithel SK, Kim HJ, Merchant NB, Cho CS, Weber SM.

J Gastrointest Surg. 2013 Jul;17(7):1209-17; discussion 1217. doi: 10.1007/s11605-013-2178-5. Epub 2013 Apr 26.

PMID:
23620151
19.

Safety and efficacy of trans arterial chemoembolization with drug-eluting beads in hepatocellular cancer: a systematic review.

Martin R, Geller D, Espat J, Kooby D, Sellars M, Goldstein R, Imagawa D, Scoggins C.

Hepatogastroenterology. 2012 Jan-Feb;59(113):255-60. doi: 10.5754/hge10240. Review.

PMID:
22251546
20.

Staging laparoscopy for proximal pancreatic cancer in a magnetic resonance imaging-driven practice: what's it worth?

Tapper E, Kalb B, Martin DR, Kooby D, Adsay NV, Sarmiento JM.

HPB (Oxford). 2011 Oct;13(10):732-7. doi: 10.1111/j.1477-2574.2011.00366.x. Epub 2011 Aug 19.

Supplemental Content

Loading ...
Support Center